Tscherpel, Caroline, Dunkl, Veronika, Ceccon, Garry, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Judov, Natalie ORCID: 0000-0002-3909-9306, Rapp, Marion, Meyer, Philipp T., Kops, Elena Rota, Ermert, Johannes ORCID: 0000-0002-2561-7766, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Shah, Nadim J., Langen, Karl-Josef ORCID: 0000-0003-1101-5075 and Galldiks, Norbert ORCID: 0000-0002-2485-1796 (2017). The use of O-(2-F-18-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord. Neuro-Oncology, 19 (5). S. 710 - 719. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Full text not available from this repository.Abstract
Despite an increasing number of O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) PET studies in supratentorial gliomas, studies regarding the usefulness of F-18-FET PET in brainstem and spinal cord gliomas to date remain scarce. Thirty-six F-18-FET PET scans were performed in 29 patients with brainstem (n = 29 scans) or spinal cord glioma (n = 7 scans). In 32 of 36 PET scans, a dynamic acquisition was performed. Fifteen scans in 15 patients were performed to assess newly diagnosed lesions, and 21 scans were obtained during follow-up: for diagnosing tumor progression (n = 15 scans in 14 patients) as well as for treatment monitoring (n = 6 scans in 3 patients). Four patients underwent additional serial scans (range, 1-2), and 3 of these 4 patients were examined for more than one indication. Maximum and mean tumor/brain ratios (TBRmax/mean) of F-18-FET uptake (20-40 min post injection) as well as kinetic F-18-FET uptake parameters were determined. Final diagnoses were confirmed histologically (54%) or by clinical follow-up (46%). In all newly diagnosed high-grade (n = 3 patients) and in 5 of 11 patients with low-grade gliomas, F-18-FET uptake was increased (TBRmax a parts per thousand 2.5 and/or TBRmean a parts per thousand 1.9). In 2 patients with newly diagnosed gliomas without MR contrast enhancement, F-18-FET PET nevertheless showed increased metabolism. At suspected progression, the combination of TBRs with kinetic F-18-FET parameters correctly identified presence or absence of progressive disease in 9 of 11 patients (82%). This preliminary study suggests that F-18-FET PET adds valuable diagnostic information in brainstem and spinal cord glioma, particularly when the diagnostic information derived from MRI is equivocal.
Item Type: | Journal Article | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Creators: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
URN: | urn:nbn:de:hbz:38-233473 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DOI: | 10.1093/neuonc/now243 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal or Publication Title: | Neuro-Oncology | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volume: | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number: | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Page Range: | S. 710 - 719 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Date: | 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Publisher: | OXFORD UNIV PRESS INC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Place of Publication: | CARY | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ISSN: | 1523-5866 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Language: | English | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Faculty: | Unspecified | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Divisions: | Unspecified | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subjects: | no entry | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Uncontrolled Keywords: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refereed: | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/23347 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |